Cancer Genetics
Why Robinhood?
You can watch CGIX and buy or sell other stocks, ETFs, and their options commission-free!About CGIX
Vyant Bio, Inc. is a biotechnology company, which engages in drug discovery for complex neurodevelopmental and neurodegenerative disorders. The firm's central nervous system (CNS) drug discovery platform combines human-derived organoid models of brain disease, scaled biology, and machine learning.
CGIX Key Statistics
Stock Snapshot
The current Cancer Genetics(CGIX) stock price is $4.61, with a market capitalization of 1.23M. The stock trades at a price-to-earnings (P/E) ratio of -0.09.
On 2026-03-03, Cancer Genetics(CGIX) stock opened at —, reached a high of —, and a low of —.
The Cancer Genetics(CGIX)'s current trading volume is 0, compared to an average daily volume of 45.95K.
In the last year, Cancer Genetics(CGIX) shares hit a 52-week high of $1.58 and a 52-week low of $0.14.
In the last year, Cancer Genetics(CGIX) shares hit a 52-week high of $1.58 and a 52-week low of $0.14.
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.